Literature DB >> 12356659

Use of drugs, alcohol and tobacco by people with schizophrenia: case-control study.

Robin G McCreadie1.   

Abstract

BACKGROUND: Specialised services should be developed to help people with schizophrenia and associated substance misuse. The extent of the problem therefore needs to be known. AIMS: To determine the use of drugs, alcohol and tobacco by people with schizophrenia drawn from rural, suburban and urban settings, and to compare use by general population control subjects.
METHOD: People with schizophrenia (n=316) and general population controls of similar gender distribution, age and postcode area of residence (n=250) were identified in rural, urban and suburban areas of Scotland. Use of drugs and alcohol was assessed by the Schedules for Clinical Assessment in Neuropsychiatry, and use of tobacco by a questionnaire.
RESULTS: More patients than controls reported problem use of drugs in the past year (22 (7%) v. 5 (2%)) and at some time before then (50 (20%) v. 15 (6%)) and problem use of alcohol in the past year (42 (17%) v. 25 (10%)) but not at some time previously (99 (40%) v. 84 (34%)). More patients were current smokers (162 (65%) v. 99 (40%)).
CONCLUSIONS: Problem use of drugs and alcohol by people with schizophrenia is greater than in the general population, but absolute numbers are small. Tobacco use is the greatest problem.

Entities:  

Mesh:

Year:  2002        PMID: 12356659     DOI: 10.1192/bjp.181.4.321

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  52 in total

1.  Injury risk and severity in a sample of Maryland residents with serious mental illness.

Authors:  Emma E McGinty; Susan P Baker; Donald M Steinwachs; Gail Daumit
Journal:  Inj Prev       Date:  2012-06-02       Impact factor: 2.399

2.  Gender differences in psychotic disorders with concurrent substance use.

Authors:  Carol L M Caton; Haiyi Xie; Robert E Drake; Gregory McHugo
Journal:  J Dual Diagn       Date:  2014

3.  The impact of substance abuse on osteoporosis screening and risk of osteoporosis in women with psychotic disorders.

Authors:  D L Kelly; C S Myers; M T Abrams; S Feldman; J Park; R P McMahon; J-C Shim
Journal:  Osteoporos Int       Date:  2010-06-09       Impact factor: 4.507

4.  A double-blind randomized clinical trial of different doses of transdermal nicotine patch for smoking reduction and cessation in long-term hospitalized schizophrenic patients.

Authors:  Hsing-Kang Chen; Tsuo-Hung Lan; Bo-Jian Wu
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-06-23       Impact factor: 5.270

5.  Predictors of smoking reduction outcomes in a sample of 287 patients with schizophrenia spectrum disorders.

Authors:  Bo-Jian Wu; Tsuo-Hung Lan
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-08-27       Impact factor: 5.270

Review 6.  Variations in rates of comorbid substance use in psychosis between mental health settings and geographical areas in the UK. A systematic review.

Authors:  Giuseppe Carrà; Sonia Johnson
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2008-11-13       Impact factor: 4.328

7.  Substance abuse and smoking among a Canadian cohort of first episode psychosis patients.

Authors:  Wayne K Deruiter; Chiachen Cheng; Margaret Gehrs; John Langley; Carolyn S Dewa
Journal:  Community Ment Health J       Date:  2013-06-18

8.  A polymorphism in the dysbindin gene (DTNBP1) associated with multiple psychiatric disorders including schizophrenia.

Authors:  Joanne Voisey; Christopher D Swagell; Ian P Hughes; Jason P Connor; Bruce R Lawford; Ross M Young; C Phillip Morris
Journal:  Behav Brain Funct       Date:  2010-07-09       Impact factor: 3.759

9.  A retrospective analysis of cannabis use in a cohort of mentally ill patients in Sri Lanka and its implications on policy development.

Authors:  Chaturaka Rodrigo; Srina Welgama; Alwis Gunawardana; Chinthaka Maithripala; Gamini Jayananda; Senaka Rajapakse
Journal:  Subst Abuse Treat Prev Policy       Date:  2010-07-08

10.  European network for promoting the physical health of residents in psychiatric and social care facilities (HELPS): background, aims and methods.

Authors:  Prisca Weiser; Thomas Becker; Carolin Losert; Köksal Alptekin; Loretta Berti; Lorenzo Burti; Alexandra Burton; Mojca Dernovsek; Eva Dragomirecka; Marion Freidl; Fabian Friedrich; Aneta Genova; Arunas Germanavicius; Ulaş Halis; John Henderson; Peter Hjorth; Taavi Lai; Jens Ivar Larsen; Katarzyna Lech; Ramona Lucas; Roxana Marginean; David McDaid; Maya Mladenova; Povl Munk-Jørgensen; Alexandru Paziuc; Petronela Paziuc; Stefan Priebe; Katarzyna Prot-Klinger; Johannes Wancata; Reinhold Kilian
Journal:  BMC Public Health       Date:  2009-08-28       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.